|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
FY2019
12 months to Dec 31, 2019
|
|
|---|---|---|---|
| Cash flows from operating activities: | |||
| Net income (loss) | |||
| Adjustments to reconcile net income (loss) to net cash provided by (used for) operating activities: | |||
| Depreciation and amortization | |||
| Amortization of right-of-use assets | |||
| Goodwill impairment | |||
| Operating lease right-of-use asset impairment | |||
| Gain on divestiture of a business | |||
| Share-based compensation expense | |||
| Benefit for deferred income taxes | |||
| Equity in earnings of affiliates | |||
| Amortization of debt issuance costs | |||
| Loss on managed exit of a business | |||
| Other | |||
| Changes in operating assets and liabilities, net of acquisitions | |||
| Accounts receivable, net | |||
| Inventories, net | |||
| Other assets and liabilities | |||
| Accounts payable and accrued expenses | |||
| Net cash provided by (used for) operating activities | |||
| Cash flows from investing activities: | |||
| Investments in property, equipment, and software | |||
| Payments related to equity investments and business acquisitions, net of cash acquired | |||
| Proceeds from divestiture of a business, net | |||
| Proceeds from sale of property and equipment | |||
| Net cash provided by (used for) investing activities | |||
| Cash flows from financing activities: | |||
| Proceeds from the issuance of debt | |||
| Proceeds from revolving line of credit | |||
| Repayment of revolving line of credit | |||
| Proceeds from issuance of debt | |||
| Principal payments of debt | |||
| Debt issuance and amendment costs | |||
| Dividend paid to Former Parent | |||
| Proceeds from share-based awards | |||
| Tax payments related to share-based awards | |||
| Net transfers from Former Parent | |||
| Proceeds from issuance of Series A preferred stock | |||
| Series A preferred stock issuance costs | |||
| Series A preferred stock dividend | |||
| Distributions to non-controlling shareholders | |||
| Deferred payments related to equity investments and business acquisitions | |||
| Payments related to the buy-out of non-controlling interests in subsidiaries of Covetrus | |||
| Net cash provided by (used for) financing activities | |||
| Effect of exchange rate changes on cash and cash equivalents | |||
| Net change in cash and cash equivalents | |||
| Cash and cash equivalents, beginning of period | |||
| Cash and cash equivalents, end of period | |||
| Supplemental disclosures of cash payments: | |||
| Interest | |||
| Income taxes | |||
| Amounts included in the measurement of operating lease liabilities | |||
| Supplemental disclosures of noncash investing and financing activities: | |||
| Conversion of Series A preferred stock | |||
| Right-of-use assets obtained in exchange for new operating lease liabilities | |||
| Right-of-use assets obtained in exchange for new financing lease liabilities | |||
| Common stock issued in business acquisition | |||
| Deconsolidation of a subsidiary |
Loading...
